1607. Clinical Outcomes at Month 6 after Initiation of Cabotegravir and Rilpivirine Long-Acting (CAB + RPV LA) in an Observational Real-World Study (BEYOND)
Sinclair, Gary I, Sension, Michael, Dretler, Alexandra, Schneider, Stefan, Schubert, Catherine K, Merrill, Deanna, Richardson, David, Sherif, Bintu, Zografos, Laurie, Garris, Cindy
Published in Open forum infectious diseases (27.11.2023)
Published in Open forum infectious diseases (27.11.2023)
Get full text
Journal Article
1288. US Healthcare Provider Perspectives on the initiation of cabotegravir and rilpivirine long-acting (CAB+RPV LA) in an observational real-world study (BEYOND)
Hsu, Ricky K, Phoenix, John, Sinclair, Gary I, Gupta, Samir K, Puga, Ana, Nguyen, Kaitlin, Schubert, Catherine K, Merrill, Deanna, Richardson, David, Nelson, Kate, Reynolds, Maria, Zografos, Laurie, Jean-Louis, Ashley, Garris, Cindy
Published in Open forum infectious diseases (15.12.2022)
Published in Open forum infectious diseases (15.12.2022)
Get full text
Journal Article